Publications
Molecular characterization of a rare case of bilateral vitreoretinal t cell lymphoma through vitreous liquid biopsy
Cani, AK,
Toral, MA,
Balikov, DA,
Betz, BL,
Hu, K,
Liu, C-J,
Prifti, MV,
Chinnaiyan, AM,
Tomlins, SA,
Mahajan, VB,
Rao, RC,
Int J Mol Sci, 2021 Jun; DOI:10.3390/ijms22116099 Reflecting on 20 years of breast cancer modeling in CISNET: Recommendations for future cancer systems modeling efforts
Trentham-Dietz, A,
Alagoz, O,
Chapman, C,
Huang, X,
Jayasekera, J,
van Ravesteyn, NT,
Lee, SJ,
Schechter, CB,
Yeh, JM,
Plevritis, SK,
Mandelblatt, JS,
Breast Working Group of the Cancer Intervention and Surveillance Modeling Network (CISNET), Array,
PLoS Comput Biol, 2021 Jun; DOI:10.1371/journal.pcbi.1009020 Squamous Cell Carcinoma of the Tongue in Young Patients: A Case Series and Literature Review
Best, DL,
Spresser, W,
Shivers, P,
Edwards, SP,
Ward, BB,
J Oral Maxillofac Surg, 2021 Jun; DOI:10.1016/j.joms.2020.12.018 Early MRI Blood Volume Changes in Constrictor Muscles Correlate With Postradiation Dysphagia
Mierzwa, ML,
Gharzai, LA,
Li, P,
Wilkie, JR,
Hawkins, PG,
Aryal, MP,
Lee, C,
Rosen, B,
Lyden, T,
Blakely, A,
Chapman, CH,
Thamarus, J,
Schonewolf, C,
Shah, J,
Eisbruch, A,
Schipper, MJ,
Cao, Y,
Int J Radiat Oncol Biol Phys, 2021 Jun; DOI:10.1016/j.ijrobp.2020.12.018 Veridical causal inference using propensity score methods for comparative effectiveness research with medical claims
Ross, RD,
Shi, X,
Caram, MEV,
Tsao, PA,
Lin, P,
Bohnert, A,
Zhang, M,
Mukherjee, B,
Health Serv Outcomes Res Methodol, 2021 Jun; DOI:10.1007/s10742-020-00222-8 Predictors of screening for cervical and colorectal cancer in women 50-65 years old in a multi-ethnic population
Harper, DM,
Plegue, M,
Sen, A,
Gorin, SS,
Jimbo, M,
Patel, MR,
Resnicow, K,
Prev Med Rep, 2021 Jun; DOI:10.1016/j.pmedr.2021.101375 Integrative Sequencing discovers an ATF1-motif Enriched Molecular Signature that differentiates Hyalinizing Clear Cell Carcinoma from Mucoepidemoid Carcinoma.
Heft Neal, ME,
Gensterblum-Miller, E,
Bhangale, AD,
Kulkarni, A,
Zhai, J,
Smith, J,
Brummel, C,
Foltin, SK,
Thomas, D,
Jiang, H,
McHugh, JB,
Brenner, JC,
Oral Oncol, 2021 Jun; DOI:10.1016/j.oraloncology.2021.105270 <sup>68</sup>Ga-DOTATATE PET/CT Imaging of Refractory Pituitary Macroadenoma Invading the Orbit
Lybik, N,
Wale, DJ,
Wong, KK,
Liao, E,
Viglianti, BL,
Clin Nucl Med, 2021 Jun; DOI:10.1097/RLU.0000000000003589 TP53 mutations and CDKN2A mutations/deletions are highly recurrent molecular alterations in the malignant progression of sinonasal papillomas
Brown, NA,
Plouffe, KR,
Yilmaz, O,
Weindorf, SC,
Betz, BL,
Carey, TE,
Seethala, RR,
McHugh, JB,
Tomlins, SA,
Udager, AM,
Mod Pathol, 2021 Jun; DOI:10.1038/s41379-020-00716-3 CD38 in Advanced Prostate Cancers
Guo, C,
Crespo, M,
Gurel, B,
Dolling, D,
Rekowski, J,
Sharp, A,
Petremolo, A,
Sumanasuriya, S,
Rodrigues, DN,
Ferreira, A,
Pereira, R,
Figueiredo, I,
Mehra, N,
Lambros, MBK,
Neeb, A,
Gil, V,
Seed, G,
Terstappen, L,
Alimonti, A,
Drake, CG,
Yuan, W,
de Bono, JS,
International SU2C PCF Prostate Cancer Dream Team, Array,
Eur Urol, 2021 Jun; DOI:10.1016/j.eururo.2021.01.017 HGG-32. ONC201 AND ONC206 TARGET TUMOR CELL METABOLISM IN PEDIATRIC DIFFUSE MIDLINE GLIOMA PRECLINICAL MODELS
Przystal, JM,
Cosentino, CC,
Yadavilli, S,
Zhang, J,
Laternser, S,
Bonner, ER,
Biery, M,
Vitanza, NA,
Koschmann, C,
Cain, J,
Waszak, SM,
Mueller, S,
Nazarian, J,
Neuro-Oncology, 2021 Jun; DOI:10.1093/neuonc/noab090.096 High-specific-activity-<sup>131</sup>I-MIBG versus <sup>177</sup>Lu-DOTATATE targeted radionuclide therapy for metastatic pheochromocytoma and paraganglioma
Jha, A,
Taïeb, D,
Carrasquillo, JA,
Pryma, DA,
Patel, M,
Millo, C,
de Herder, WW,
Del Rivero, J,
Crona, J,
Shulkin, BL,
Virgolini, I,
Chen, AP,
Mittal, BR,
Basu, S,
Dillon, JS,
Hope, TA,
Mari Aparici, C,
Iagaru, AH,
Hicks, RJ,
Avram, AM,
Strosberg, JR,
Civelek, AC,
Lin, FI,
Pandit-Taskar, N,
Pacak, K,
Clin Cancer Res, 2021 Jun; DOI:10.1158/1078-0432.CCR-20-3703 Chronic difficulties are associated with poorer psychosocial functioning in the first year post-diagnosis in epithelial ovarian cancer patients
Garvin, L,
Slavich, GM,
Schrepf, A,
Davis, LZ,
Thaker, PH,
Goodheart, MJ,
Cole, SW,
Sood, AK,
Lutgendorf, SK,
Psychooncology, 2021 Jun; DOI:10.1002/pon.5682 EPCT-07. ID1 IS A KEY TRANSCRIPTIONAL REGULATOR OF DIPG INVASION AND IS TARGETABLE WITH CANNABIDIOL
Yadav, VN,
Harris, MK,
Thomas, C,
Stallard, S,
Woo, R,
Siddaway, R,
Qin, T,
Cummings, JR,
Mullan, B,
Siada, R,
Ravindran, R,
Niculcea, M,
Cao, X,
Castro, MG,
Lowenstein, PR,
Mody, R,
Chinnaiyan, A,
Hawkins, C,
Desprez, P,
McAllister, S,
Venneti, S,
Koschmann, C,
Neuro-Oncology, 2021 Jun; DOI:10.1093/neuonc/noab090.193 Positive Psychosocial Factors and Oxytocin in the Ovarian Tumor Microenvironment
Cuneo, MG,
Szeto, A,
Schrepf, A,
Thaker, PH,
Goodheart, M,
Cole, SW,
Sood, AK,
McCabe, PM,
Mendez, AJ,
Lutgendorf, SK,
Psychosom Med, 2021 Jun; DOI:10.1097/PSY.0000000000000935 Single nucleotide polymorphism array and cytogenetic analyses of ovarian teratomas in children.
Shao, L,
Heider, A,
Rabah, R,
Genes Chromosomes Cancer, 2021 Jun; DOI:10.1002/gcc.22934 Cancer cell intrinsic and immunologic phenotypes determine clinical outcomes in basal-like breast cancer
Li, CI,
Zhang, Y,
Cieślik, M,
Wu, Y-M,
Xiao, L,
Cobain, E,
Tang, M-TC,
Cao, X,
Porter, P,
Guenthoer, J,
Robinson, DR,
Chinnaiyan, AM,
Clin Cancer Res, 2021 Jun; DOI:10.1158/1078-0432.CCR-20-3890 A New Prognostic Model in Patients with Advanced Urothelial Carcinoma Treated with First-line Immune Checkpoint Inhibitors
Khaki, AR,
Li, A,
Diamantopoulos, LN,
Miller, NJ,
Carril-Ajuria, L,
Castellano, D,
De Kouchkovsky, I,
Koshkin, V,
Park, J,
Alva, A,
Bilen, MA,
Stewart, T,
Santos, V,
Agarwal, N,
Jain, J,
Zakharia, Y,
Morales-Barrera, R,
Devitt, M,
Nelson, A,
Hoimes, CJ,
Shreck, E,
Gartrell, BA,
Sankin, A,
Tripathi, A,
Zakopoulou, R,
Bamias, A,
Rodriguez-Vida, A,
Drakaki, A,
Liu, S,
Kumar, V,
Lythgoe, MP,
Pinato, DJ,
Murgic, J,
Fröbe, A,
Joshi, M,
Isaacsson Velho, P,
Hahn, N,
Alonso Buznego, L,
Duran, I,
Moses, M,
Barata, P,
Galsky, MD,
Sonpavde, G,
Yu, EY,
Shankaran, V,
Lyman, GH,
Grivas, P,
Eur Urol Oncol, 2021 Jun; DOI:10.1016/j.euo.2020.12.006 Potential Molecular Targets in the Setting of Chemoradiation for Esophageal Malignancies
Jabbour, SK,
Williams, TM,
Sayan, M,
Miller, ED,
Ajani, JA,
Chang, AC,
Coleman, N,
El-Rifai, W,
Haddock, M,
Ilson, D,
Jamorabo, D,
Kunos, C,
Lin, S,
Liu, G,
Prasanna, PG,
Rustgi, AK,
Wong, R,
Vikram, B,
Ahmed, MM,
J Natl Cancer Inst, 2021 Jun; DOI:10.1093/jnci/djaa195 Low Incidence of Adverse Outcomes in Adults With Chronic Hepatitis B Virus Infection in the Era of Antiviral Therapy
Lok, AS,
Perrillo, R,
Lalama, CM,
Fried, MW,
Belle, SH,
Ghany, MG,
Khalili, M,
Fontana, RJ,
Sterling, RK,
Terrault, N,
Feld, JJ,
Di Bisceglie, AM,
Lau, DTY,
Hassan, M,
Janssen, HLA,
Hepatitis B Research Network (HBRN), Array,
Hepatology, 2021 Jun; DOI:10.1002/hep.31554 Measuring Tumor Microenvironment pH during Radiotherapy Using a Novel Cerenkov Emission Multispectral Optical Probe based on Silicon Photomultipliers
Oraiqat, IM,
Al-Snayyan, E,
Calcaterra, A,
Clarke, R,
Naqa, ARIE,
Frontiers in Physics, 2021 Jun; The Landmark Series: Multimodal Therapy for Esophageal Cancer.
Demarest, CT,
Chang, AC,
Ann Surg Oncol, 2021 Jun; DOI:10.1245/s10434-020-09565-5 Genetic analysis of sinonasal undifferentiated carcinoma discovers recurrent SWI/SNF alterations and a novel PGAP3-SRPK1 fusion gene
Heft Neal, ME,
Birkeland, AC,
Bhangale, AD,
Zhai, J,
Kulkarni, A,
Foltin, SK,
Jewell, BM,
Ludwig, ML,
Pinatti, L,
Jiang, H,
McHugh, JB,
Marentette, L,
McKean, EL,
Brenner, JC,
BMC Cancer, 2021 May; DOI:10.1186/s12885-021-08370-x Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)
Han, SY,
Mrózek, K,
Voutsinas, J,
Wu, Q,
Morgan, EA,
Vestergaard, H,
Ohgami, R,
Kluin, PM,
Kristensen, TK,
Pullarkat, S,
Møller, MB,
Schiefer, A-I,
Baughn, LB,
Kim, Y,
Czuchlewski, D,
Hilberink, JR,
Horny, H-P,
George, TI,
Dolan, M,
Ku, NK,
Arana Yi, C,
Pullarkat, V,
Kohlschmidt, J,
Salhotra, A,
Soma, L,
Bloomfield, CD,
Chen, D,
Sperr, WR,
Marcucci, G,
Cho, C,
Akin, C,
Gotlib, J,
Broesby-Olsen, S,
Larson, M,
Linden, MA,
Deeg, HJ,
Hoermann, G,
Perales, M-A,
Hornick, JL,
Litzow, MR,
Nakamura, R,
Weisdorf, D,
Borthakur, G,
Huls, G,
Valent, P,
Ustun, C,
Yeung, CCS,
Blood Adv, 2021 May; DOI:10.1182/bloodadvances.2020003605 Efficacy and safety of rucaparib in previously treated, locally advanced or metastatic urothelial carcinoma from a phase 2, open-label trial (ATLAS)
Grivas, P,
Loriot, Y,
Morales-Barrera, R,
Teo, MY,
Zakharia, Y,
Feyerabend, S,
Vogelzang, NJ,
Grande, E,
Adra, N,
Alva, A,
Necchi, A,
Rodriguez-Vida, A,
Gupta, S,
Josephs, DH,
Srinivas, S,
Wride, K,
Thomas, D,
Simmons, A,
Loehr, A,
Dusek, RL,
Nepert, D,
Chowdhury, S,
BMC Cancer, 2021 May; DOI:10.1186/s12885-021-08085-z 